Ticker Attention Investors: Beware of fraudulent Calls, SMS, Emails, WhatsApp & Telegram messages assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Elevate App only from Google Play Store or Apple App Store or login to Elevate Web portal. Click Here to know more.

Aditya Birla Money Limited

Aditya Birla Money Limited

Lactose (India) Ltd

Symbol : Not Listed | BSE Code : 524202 | Sector : PHARMACEUTICALS - INDIAN - BULK DRUGS

Market Cap (₹ Cr.)

Today’s High / Low
52 Week High / Low
OVERVIEW
  • Open
  • Prev. Close
  • High
  • Low
  • Market Cap (₹ Cr.)
  • 52 Week High
  • 52 Week Low
  • Traded Volume (Lacs)
  • Traded Value (Cr)
  • Dividend Yield
  • 0.00
  • Face Value
  • 10.00
  • EPS
  • 4.91
  • P/E
  • 21.50
  • Beta (1 year)
  • 1.02
LAST 5 DAYS

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 34.09%

  • 09/05/2025 BSE
    -2.15(-2.00)
    Close Price: ₹ 105.55
    Volume: 263.00

    08-May-2025
  • 09/05/2025 BSE
    -2.15(-1.96)
    Close Price: ₹ 107.70
    Volume: 356.00

    07-May-2025
  • 09/05/2025 BSE
    -2.20(-1.96)
    Close Price: ₹ 109.85
    Volume: 287.00

    06-May-2025
  • 09/05/2025 BSE
    -2.25(-1.97)
    Close Price: ₹ 112.05
    Volume: 291.00

    05-May-2025
  • 09/05/2025 BSE
    -2.29(-1.96)
    Close Price: ₹ 114.30
    Volume: 169.00

    02-May-2025

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 34.09%

  • Stock Absolute
  • -7.66
  • 0.47
  • -24.74
  • 42.25
  • 484.76
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • -0.21
  • 8.23
  • 9.35
  • 47.48
  • 153.88
NEWS

Lactose (India) standalone net profit declines 91.63% in the December 2024 quarter

13-Feb-2025

Net profit of Lactose (India) declined 91.63% to Rs 0.22 crore in the quarter ended December 2024 as against Rs 2.63 crore during the previous quarter ended December 2023. Sales declined 11.90% to Rs 28.72 crore in the quarter ended December 2024 as against Rs 32.60 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales28.7232.60 -12
OPM %10.3417.58 -
PBDT1.894.80 -61
PBT0.543.60 -85
NP0.222.63 -92

13
Feb

Lactose (India) standalone net profit declines 91.63% in the December 2024 quarter



13
Feb

Lactose (India) Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication



12
Feb

Lactose (India) Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday 12Th February 2025



FINANCIAL DATA

In Cr.

Mar 2024Mar 2023Mar 2022
SOURCES OF FUNDS :   
Share Capital 12.5912.5912.59
Reserves Total 34.5127.9726.70
Equity Share Warrants0.000.000.00
Equity Application Money0.000.000.00
Read More
Mar 2024Mar 2023Mar 2022
INCOME :   
Sales Turnover 113.8965.8045.94
Excise Duty0.000.000.00
Net Sales113.8965.8045.94
Other Income 1.120.720.58
Read More
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales 28.7230.4529.46
Excise Duty 000
Net Sales 28.7230.4529.46
Other Operating Income 000
Other Income  0.560.300.22
Read More
Category No. Of Shares Percentage (%)
Total Foreign 51512 0.41
Total Institutions 77920 0.62
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 774899 6.16
Total Promoters 6753426 53.65
Total Public & others 4,931,243.00 39.17
Total 100.00 100.00
Read More
CORPORATE ACTIONS
Record Date Ex-Bonus Date Ratio
nodata
No Data Available!!!
Read More
Record Date Split Date Face Value Before Face Value After
nodata
No Data Available!!!
Read More
ANNOUNCEMENT DATE EX DIVIDEND DATE DIVIDEND (%) DIVIDEND TYPE
nodata
No Data Available!!!
Read More
PREMIUM (₹) RATIO RECORD DATE EX RIGHTS DATE
nodata
No Data Available!!!
Read More
Read More
FROM DATE EX TO DATE AGENDA
12-02-2025 NA LACTOSE (INDIA) LTD.has inform...
05-12-2024 NA Inter alia, to consider and ap...
15-11-2024 NA Pursuant to Regulation 30 and ...
15-11-2024 NA Pursuant to Regulation 30 of S...
09-11-2024 15-11-2024 Pursuant to Regulation 30 and ...
COMPANY INFO

Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, they engage in the contract manufacture of pharmaceutical products.

The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad.

The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose.

In the year 1994, the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections, namely capsule section, tablet section and indictable section.

During the year 1995-96, the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condensed milk casein powder.

During the year 2004-05, the company streamlined their pharm

Read More